DaVita Inc. (NYSE: DVA) stock closed at 109.85 per share at the end of the most recent trading day (a 1.5% change compared to the prior day closing price) with a volume of 764.28K shares and market capitalization of 12.22B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 67000 people. DaVita Inc. CEO is Javier J. Rodriguez.

The one-year performance of DaVita Inc. stock is 45.44%, while year-to-date (YTD) performance is -6.43%. DVA stock has a five-year performance of 48.03%. Its 52-week range is between 71.7 and 125.28, which gives DVA stock a 52-week price range ratio of 74.69%

DaVita Inc. currently has a PE ratio of 17.00, a price-to-book (PB) ratio of 8.41, a price-to-sale (PS) ratio of 1.37, a price to cashflow ratio of 6.60, a PEG ratio of 2.32, a ROA of 4.32%, a ROC of 8.41% and a ROE of 41.75%. The company’s profit margin is 8.04%, its EBITDA margin is 19.50%, and its revenue ttm is $8.71 Billion , which makes it $80.00 revenue per share.

Of the last four earnings reports from DaVita Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.79 for the next earnings report. DaVita Inc.’s next earnings report date is 04th May 2021.

The consensus rating of Wall Street analysts for DaVita Inc. is Moderate Buy (2.25), with a target price of $132.67, which is +18.99% compared to the current price. The earnings rating for DaVita Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

DaVita Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

DaVita Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 10.34, ATR14 : 3.11, CCI20 : 84.08, Chaikin Money Flow : -0.02, MACD : -0.44, Money Flow Index : 55.69, ROC : -0.18, RSI : 54.01, STOCH (14,3) : 81.82, STOCH RSI : 0.95, UO : 46.44, Williams %R : -18.18), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of DaVita Inc. in the last 12-months were: Barbara J. Desoer (Option Excercise at a value of $260 153), Barbara J. Desoer (Sold 1 388 shares of value $154 068 ), Charles G. Berg (Option Excercise at a value of $759 999), Charles G. Berg (Sold 714 shares of value $62 498 ), John M. Nehra (Buy at a value of $461 188), John M. Nehra (Option Excercise at a value of $759 999), Kathleen Alyce Waters (Sold 10 000 shares of value $1 050 129 ), Kent J. Thiry (Option Excercise at a value of $10 975 269), Kent J. Thiry (Sold 129 390 shares of value $10 491 928 ), Leanne M. Zumwalt (Option Excercise at a value of $2 680 720), Leanne M. Zumwalt (Sold 3 772 shares of value $332 031 ), Michael David Staffieri (Option Excercise at a value of $7 443 003), Michael David Staffieri (Sold 25 000 shares of value $2 743 515 ), Pamela M. Arway (Option Excercise at a value of $2 089 922), Pamela M. Arway (Sold 11 260 shares of value $1 169 402 ), Paul J. Diaz (Option Excercise at a value of $2 089 922), Paul J. Diaz (Sold 11 526 shares of value $947 650 ), Peter T. Grauer (Option Excercise at a value of $4 994 936), R. Ted Weschler (Sold 2 200 000 shares of value $193 600 000 ), William L. Roper (Option Excercise at a value of $759 999), William L. Roper (Sold 714 shares of value $61 967 )